Our research is within basic sarcoma biology with the aim to outline molecular mechanism of tumor development whit the ultimate goal to develop targeted therapies. Furthermore, we are developing and implementing next generation cancer diagnostics based on liquid biopsy-based biomarker analysis in cancer management. To accomplish these efforts, we have developed several molecular technologies and have access to our own clinical trial.
Anders Ståhlberg
University of Gothenburg
Key Publications
Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab
Immuno-Oncology and Technology, 2025
Identification of protein biomarkers to differentiate between gram-negative and gram-positive infections in adults suspected of sepsis
BMC Infectious Diseases, 2025
Ultrasensitive Sequencing (SiMSen‐Seq) for Environmental DNA Applications
Environmental DNA, 2025
Identifying Key Questions and Challenges in Microchimerism Biology.
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025
Patient-specific sequencing panels enable sensitive circulating tumor DNA analysis in rhabdomyosarcoma independent of genetic profile.
NPJ precision oncology, 2025